Recommendations for decision and simulation modeling

Project Summary Title and Description

Title
Recommendations for decision and simulation modeling
Description
Purpose: We aimed to update and expand previous syntheses of evidence- and consensus-based guidance on decision and simulation modeling using a systematic review-driven stakeholder-led process.
Attribution
N/A
Authors of Report
N/A
Methodology description
Data sources: We searched MEDLINE, the Cochrane Methodology Register, the Health Technology Assessment Database, and the NHS Economic Evaluation Database (through October 30, 2012) Study selection: We selected articles presenting evidence- or consensus-based recommendations for the conduct and dissemination of decision and simulation modeling.
PROSPERO
CRD42013006197
DOI
10.7301/Z02N506T
Notes
Prospective entry of data. Report publication (final citation pending): Dahabreh IJ, Chan JA, Earley A, Moorthy D, Avendano EE, Trikalinos TA, Balk EM, Wong JB. Modeling and Simulation in the Context of Health Technology Assessment: Review of Existing Guidance, Future Research Needs, and Validity Assessment. Methods Report No. pdg. (Prepared by the Tufts Evidence-based Practice Center under Contract No. HHSA 290 2007 10055 I.) AHRQ Publication No. XX-EHCXXX-EF. Rockville, MD: Agency for Healthcare Research and Quality. <Month Year>. www.effectivehealthcare.ahrq.gov/reports/final.cfm.
Funding Source
AHRQ Contract No. HHSA 290 2007 10055 I

Key Questions

1. Recommendation Extractions

Associated Extraction Forms

Associated Studies (each link opens a new tab)

TitleAuthorsYear
Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making.2009
Pharmacoeconomic guidelines and their implementation in the positive list system in South Korea.-- Not Found --
Can economic evaluations be made more transferable?2005
A taxonomy of model structures for economic evaluation of health technologies.2006
Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6.
Guidelines for the economic evaluation of health technologies: Canada2006
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.2010
Development and validation of a grading system for the quality of cost-effectiveness studies.2003
Belgian methodological guidelines for pharmacoeconomic evaluations: toward standardization of drug reimbursement requests.
Methodological and conduct principles for pharmacoeconomic research. Pharmaceutical Research and Manufacturers of America.1995
Economic evaluation of telemedicine: review of the literature and research guidelines for benefit-cost analysis.2009
Standardizing methodologies for economic evaluation in health care. Practice, problems, and potential.1993
Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies.
Common methodological flaws in economic evaluations.2005
Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report.2009
Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria.2005
The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report.
A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics.1995
Clinical heterogeneity in systematic reviews and health technology assessments: synthesis of guidance documents and the literature.2012
The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals.1999
Empirically evaluating decision-analytic models.2010
Bridging trial and decision: a checklist to frame health technology assessments for resource allocation decisions.-- Not Found --
Panel 2: methodological issues in conducting pharmacoeconomic evaluations--modeling studies.-- Not Found --
Methodological quality of economic evaluations of new pharmaceuticals in The Netherlands.2012
A critique and impact analysis of decision modeling assumptions.-- Not Found --
A review and critique of modelling in prioritising and designing screening programmes.2007
What aspects of the health technology assessment process recommended by international health technology assessment agencies received the most attention in Poland in 2008?2011
EUR-ASSESS Project Subgroup report on Methodology. Methodological guidance for the conduct of health technology assessment.1997
Spanish recommendations on economic evaluation of health technologies.2010
The United Kingdom guidelines for the economic evaluation of medicines.
Methods of cost-effectiveness analysis: areas of consensus and debate.-- Not Found --
The generalisability of pharmacoeconomic studies.1997
Testing the validity of cost-effectiveness models.
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.-- Not Found --
Canada's new guidelines for the economic evaluation of pharmaceuticals.
What you don't know can't hurt you? Statistical issues and standards for medical technology evaluation.1996
Emerging standardization in pharmacoeconomics.-- Not Found --
Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making.2002
Development of WHO guidelines on generalized cost-effectiveness analysis.2000
The quality of reporting in published cost-utility analyses, 1976-1997.2000
Decision analytic modelling in the economic evaluation of health technologies. A consensus statement. Consensus Conference on Guidelines on Economic Modelling in Health Technology Assessment.2000
Modeling the annual costs of postmenopausal prevention therapy: raloxifene, alendronate, or estrogen-progestin therapy.-- Not Found --
Classification of evidence in decision-analytic models of cost-effectiveness: a content analysis of published reports.2010
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.-- Not Found --
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2.
The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine.1996
Economic evaluation of diagnostic technology. Methodological challenges and viable solutions.1997
Generalisability in economic evaluation studies in healthcare: a review and case studies.2004
Economic evaluation of diagnostic tests. A review of published studies.1999
Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine.1997
Toward a peer review process for medical decision analysis models.1994
Health economic evaluations using decision analytic modeling. Principles and practices--utilization of a checklist to their development and appraisal.2002
Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health Care Technology.1995
The use of surrogate outcomes in model-based cost-effectiveness analyses: a survey of UK Health Technology Assessment reports.2009
Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations.-- Not Found --
Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?1992
The Pediatric Quality Appraisal Questionnaire: an instrument for evaluation of the pediatric health economics literature.-- Not Found --
Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines.2008
Methods for determining cost-benefit ratios for pharmaceuticals in Germany.2007
Recommendations of the Panel on Cost-effectiveness in Health and Medicine.1996
Reporting format for economic evaluation. Part II: Focus on modelling studies.1998
German recommendations on health economic evaluation: third and updated version of the Hanover Consensus.-- Not Found --
Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada.1993
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.-- Not Found --
Quality of clinical and economic evidence in dossier formulary submissions.2007
Review of guidelines for good practice in decision-analytic modelling in health technology assessment.2004
Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.1996
Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.-- Not Found --
Methodologic evaluation of the radiology cost-effectiveness literature.1997

Downloadable Data Content

Files
  • XLSX Project Data